2 UK growth and value stocks I’d buy to hold until 2030!

I think these value stocks are too good for growth investors to ignore. I reckon they could deliver exceptional returns through to the end of the decade.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young Asian man drinking coffee at home and looking at his phone

Image source: Getty Images

Here are two top UK growth and value stocks I’m looking to buy when I have spare cash to invest.

Spire Healthcare

Chronic underfunding in the NHS has led to an explosion in waiting lists. It’s why I’ve opened a position in private hospital operator Spire Healthcare (LSE:SPI) and plan to buy more.

Research from the Private Healthcare Information Network shows that a record 272,000 patients funded medical treatment themselves last year. The number of people receiving care through insurance policies is also booming as NHS waiting lists grow. Latest data showed a record 7.33m people awaiting state-funded treatment.

Spire — which owns 39 hospitals and 33 clinics across the country — continues to make solid progress against this backdrop. It said this month its “good momentum” has continued since the end of last year. In 2022, the business saw revenues rise 8.3% to £1.2bn, while adjusted operating profit leapt 30.2% year on year to £105.6m.

Staff shortages and the upward pressure this is placing on wages is affecting profits here. But price rises, along with a favourable treatment mix and cost savings, mean the business keeps making exceptional progress when it comes to margins. Its adjusted EBITDA margin improved 90 basis points last year to 17%.

City analysts expect annual earnings to rise 48% in 2023. They predict bottom-line rises of 61% and 33% too, in 2024 and 2025 respectively, as the NHS patient exodus continues.

And these predictions leave Spire trading on a forward price-to-earnings growth (PEG) ratio of just 0.8. Any reading below 1 suggests a stock is undervalued.

Redcentric

Purchasing tech stocks could be another good idea as the pivot towards flexible working gathers pace. Redcentric (LSE:RCN) is one such London-listed company on my radar.

Employee demands for an improved work/life balance have soared since Covid. And huge labour shortages across the West mean that businesses are having to bend to worker demands, including working from home.

Lawmakers are taking steps to help workers stay away from the office too. In the UK, for example, The Employment Relations (Flexible Working) Bill that’s going through parliament will allow people to request flexible working from Day One of their employment.

This all bodes well for Redcentric. The business provides cloud computing services that allow workers to access, manage and share project data from anywhere. It also provides expertise in cyber security, communications and other areas critical for effective and safe flexible working. This helped revenues rise 52% in the last financial year (to March) to $141.8m.

Smaller operators like this face huge competition from industry giants such as Microsoft. But the exceptional progress it has made so far still makes it an attractive stock to own, in my opinion.

Analysts expect annual earnings here to rise 96% in financial 2024. This leaves the tech firm trading on a PEG ratio of just 0.1.

Royston Wild has positions in Spire Healthcare Group Plc. The Motley Fool UK has recommended Microsoft. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

The best time to buy stocks? It might be right now

Short-term issues that delay long-term trends create opportunities to buy stocks. And that could be happening right now with a…

Read more »

Queen Street, one of Cardiff's main shopping streets, busy with Saturday shoppers.
Investing Articles

Here’s why Next stock rose 5% and topped the FTSE 100 today

Next was the leading FTSE 100 stock today, rising 5%. Our writer takes a look at why and asks if…

Read more »

Renewable energies concept collage
Investing Articles

Up 458% in a year, could the Ceres Power share price go even higher?

Christopher Ruane reviews some highs and lows of the Ceres Power share price over the years and wonders whether the…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Are the glory days over for Rolls-Royce shares?

Rolls-Royce shares have soared in recent years. Lately, though, they have taken a tumble. Could there be worse still to…

Read more »

Group of friends meet up in a pub
Investing Articles

Are ‘66% off’ Diageo shares a once-in-a-decade opportunity?

Diageo shares have taken another hit in the early weeks of 2026. Are we looking at a massive bargain or…

Read more »

Investing Articles

Meet the UK stock under £1.50 smashing Rolls-Royce shares over the past year

While Rolls-Royce shares get all the attention, this under-the-radar trust has quietly made investors a fortune. But is it still…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Down 19%, the red lights are flashing for Barclays shares!

Barclays shares have fallen almost a fifth in value as the Middle East war has intensified. Royston Wild argues that…

Read more »

Aviva logo on glass meeting room door
Investing Articles

After falling another 5%, are Aviva shares too cheap to ignore?

£10,000 invested in Aviva shares five years ago would have grown 50% by now. But what might the future hold,…

Read more »